Literature DB >> 24685721

Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication.

Elisavet Serti1, Jens M Werner1, Michael Chattergoon2, Andrea L Cox2, Volker Lohmann3, Barbara Rehermann4.   

Abstract

BACKGROUND & AIMS: Production of interferon (IFN)-γ by natural killer (NK) cells is attenuated during chronic infection with hepatitis C virus (HCV). We investigated whether this is due to intrinsic or extrinsic mechanisms of NK cells.
METHODS: Peripheral blood mononuclear cells (PBMCs) were collected from patients with chronic HCV infection or uninfected blood donors (controls); NK cells and monocytes were isolated or eliminated. We cultured hepatoma cells that express luciferase-tagged subgenomic HCV replicons (Huh7/HCV replicon cells) or their HCV-negative counterparts (Huh7) with NK cells in the presence or absence of other populations of PBMCs. Antiviral activity, cytotoxicity, and cytokine production were assessed.
RESULTS: NK cells produced greater amounts of IFN-γ when PBMC were cocultured with Huh7/HCV replicon cells than with Huh7 cells; NK cells and PBMCs from controls suppressed HCV replication to a greater extent than those from patients with chronic HCV infection. This antiviral effect was predominantly mediated by tumor necrosis factor (TNF)-α and IFN-γ. The antiviral activity of NK cells and their production of IFN-γ were reduced when they were used in coculture alone (rather than with PBMC), or after depletion of CD14(+) monocytes, after knockdown of the inflammasome in monocytes, or after neutralization of interleukin-18, which is regulated by the inflammasome. These findings indicate a role for monocytes in NK cell activation. Compared with control monocytes, monocytes from patients with chronic HCV infection had reduced TNF-α-mediated (direct) and reduced NK cell-mediated (indirect) antiviral effects. Control monocytes increased the antiviral effects of NK cells from patients with chronic HCV infection and their production of IFN-γ.
CONCLUSIONS: Monocytes sense cells that contain replicating HCV and respond by producing interleukin-18 via the inflammasome and by activating NK cells. Patients with chronic HCV infection have reduced monocyte function, attenuating NK cell IFN-γ-mediated responses.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokine Production; Hepatocyte; Immune Response; Viral Replication

Mesh:

Substances:

Year:  2014        PMID: 24685721      PMCID: PMC4469643          DOI: 10.1053/j.gastro.2014.03.046

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

1.  Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection.

Authors:  Eui-Cheol Shin; Ulrike Seifert; Takanobu Kato; Charles M Rice; Stephen M Feinstone; Peter-M Kloetzel; Barbara Rehermann
Journal:  J Clin Invest       Date:  2006-10-12       Impact factor: 14.808

2.  Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

Authors:  Joo Chun Yoon; Masaaki Shiina; Golo Ahlenstiel; Barbara Rehermann
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

3.  Genomic analysis of the host response to hepatitis C virus infection.

Authors:  Andrew I Su; John P Pezacki; Lisa Wodicka; Amy D Brideau; Lubica Supekova; Robert Thimme; Stefan Wieland; Jens Bukh; Robert H Purcell; Peter G Schultz; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-19       Impact factor: 11.205

4.  Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration.

Authors:  V Pétrilli; S Papin; C Dostert; A Mayor; F Martinon; J Tschopp
Journal:  Cell Death Differ       Date:  2007-06-29       Impact factor: 15.828

5.  Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages.

Authors:  Mihai G Netea; Claudia A Nold-Petry; Marcel F Nold; Leo A B Joosten; Bastian Opitz; Jonathan H M van der Meer; Frank L van de Veerdonk; Gerben Ferwerda; Bas Heinhuis; Isabel Devesa; C Joel Funk; Robert J Mason; Bart Jan Kullberg; Anna Rubartelli; Jos W M van der Meer; Charles A Dinarello
Journal:  Blood       Date:  2008-12-22       Impact factor: 22.113

6.  Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.

Authors:  Heiner Wedemeyer; Xiao-Song He; Michelina Nascimbeni; Anthony R Davis; Harry B Greenberg; Jay H Hoofnagle; T Jake Liang; Harvey Alter; Barbara Rehermann
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

7.  Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.

Authors:  Svetlana Marukian; Christopher T Jones; Linda Andrus; Matthew J Evans; Kimberly D Ritola; Edgar D Charles; Charles M Rice; Lynn B Dustin
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

8.  Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-gamma responses to malaria.

Authors:  Kirsty C Newman; Daniel S Korbel; Julius C Hafalla; Eleanor M Riley
Journal:  PLoS Pathog       Date:  2006-12       Impact factor: 6.823

9.  Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.

Authors:  Stefania Crotta; Annalisa Stilla; Andreas Wack; Annalisa D'Andrea; Sandra Nuti; Ugo D'Oro; Marta Mosca; Franco Filliponi; R Maurizia Brunetto; Ferruccio Bonino; Sergio Abrignani; Nicholas M Valiante
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

10.  IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation.

Authors:  Erwan Mortier; Tammy Woo; Rommel Advincula; Sara Gozalo; Averil Ma
Journal:  J Exp Med       Date:  2008-05-05       Impact factor: 14.307

View more
  46 in total

Review 1.  The contrasting roles of inflammasomes in cancer.

Authors:  Qin He; Yu Fu; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Editorial Commentary: Another Call to Cure Hepatitis B.

Authors:  Ashwin Balagopal; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2015-06-16       Impact factor: 9.079

3.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

Review 4.  Organ system view of the hepatic innate immunity in HCV infection.

Authors:  Bo-Ram Bang; Sandra Elmasry; Takeshi Saito
Journal:  J Med Virol       Date:  2016-05-13       Impact factor: 2.327

5.  Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.

Authors:  Fabian J Bolte; Ashley C O'Keefe; Lauren M Webb; Elisavet Serti; Elenita Rivera; T Jake Liang; Marc Ghany; Barbara Rehermann
Journal:  Gastroenterology       Date:  2017-08-02       Impact factor: 22.682

6.  Soluble Fc-Disabled Herpes Virus Entry Mediator Augments Activation and Cytotoxicity of NK Cells by Promoting Cross-Talk between NK Cells and Monocytes.

Authors:  Qinglai Meng; Asifa K Zaidi; John Sedy; Armand Bensussan; Daniel L Popkin
Journal:  J Immunol       Date:  2019-02-15       Impact factor: 5.422

7.  TNFα Augments Cytokine-Induced NK Cell IFNγ Production through TNFR2.

Authors:  Wagdi Almishri; Tania Santodomingo-Garzon; Tyson Le; Danuta Stack; Christopher H Mody; Mark G Swain
Journal:  J Innate Immun       Date:  2016-08-25       Impact factor: 7.349

8.  Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα.

Authors:  Elisavet Serti; Heiyoung Park; Meghan Keane; Ashley C O'Keefe; Elenita Rivera; T Jake Liang; Marc Ghany; Barbara Rehermann
Journal:  Gut       Date:  2016-01-04       Impact factor: 23.059

Review 9.  Inflammasome activation and function in liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

Review 10.  Innate and Adaptive Immune Responses in Chronic HCV Infection.

Authors:  Lynn B Dustin
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.